Biohaven Pharmaceutical Stock Forecast - Accumulation Distribution
| BHVN Stock | USD 46.01 0.37 0.80% |
Biohaven Stock Forecast is based on your current time horizon. Although Biohaven Pharmaceutical's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Biohaven Pharmaceutical's systematic risk associated with finding meaningful patterns of Biohaven Pharmaceutical fundamentals over time.
Biohaven |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 16978.84 | 32950.29 |
| Check Biohaven Pharmaceutical Volatility | Backtest Biohaven Pharmaceutical | Trend Details |
Biohaven Pharmaceutical Trading Date Momentum
| On September 13 2024 Biohaven Pharmaceutical Holding was traded for 38.08 at the closing time. The top price for the day was 38.11 and the lowest listed price was 36.16 . The trading volume for the day was 614.4 K. The trading history from September 13, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 6.52% . The overall trading delta against the current closing price is 11.02% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Biohaven Pharmaceutical to competition |
Other Forecasting Options for Biohaven Pharmaceutical
For every potential investor in Biohaven, whether a beginner or expert, Biohaven Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Biohaven Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Biohaven. Basic forecasting techniques help filter out the noise by identifying Biohaven Pharmaceutical's price trends.View Biohaven Pharmaceutical Related Equities
| Risk & Return | Correlation |
Biohaven Pharmaceutical Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Biohaven Pharmaceutical's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Biohaven Pharmaceutical's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Biohaven Pharmaceutical Market Strength Events
Market strength indicators help investors to evaluate how Biohaven Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biohaven Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Biohaven Pharmaceutical stock market strength indicators, traders can identify Biohaven Pharmaceutical Holding entry and exit signals to maximize returns.
| Accumulation Distribution | 15094.83 | |||
| Daily Balance Of Power | (0.27) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 46.64 | |||
| Day Typical Price | 46.43 | |||
| Price Action Indicator | (0.81) | |||
| Period Momentum Indicator | (0.37) | |||
| Relative Strength Index | 54.82 |
Biohaven Pharmaceutical Risk Indicators
The analysis of Biohaven Pharmaceutical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Biohaven Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting biohaven stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.47 | |||
| Semi Deviation | 2.41 | |||
| Standard Deviation | 3.52 | |||
| Variance | 12.36 | |||
| Downside Variance | 6.56 | |||
| Semi Variance | 5.82 | |||
| Expected Short fall | (3.14) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Biohaven Pharmaceutical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biohaven Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biohaven Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.Moving together with Biohaven Stock
Moving against Biohaven Stock
| 0.59 | ELAN | Elanco Animal Health | PairCorr |
| 0.56 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.48 | TAK | Takeda Pharmaceutical | PairCorr |
| 0.46 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
| 0.43 | INAB | In8bio Inc | PairCorr |
The ability to find closely correlated positions to Biohaven Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biohaven Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biohaven Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biohaven Pharmaceutical Holding to buy it.
The correlation of Biohaven Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biohaven Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biohaven Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biohaven Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Biohaven Pharmaceutical to cross-verify your projections. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biohaven Pharmaceutical. If investors know Biohaven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biohaven Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.37) | Return On Assets (1.19) | Return On Equity (2.65) |
The market value of Biohaven Pharmaceutical is measured differently than its book value, which is the value of Biohaven that is recorded on the company's balance sheet. Investors also form their own opinion of Biohaven Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biohaven Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biohaven Pharmaceutical's market value can be influenced by many factors that don't directly affect Biohaven Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biohaven Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biohaven Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biohaven Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.